According to YH Research, the global market for RNA Oligonucleotide Synthesis Service should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China RNA Oligonucleotide Synthesis Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States RNA Oligonucleotide Synthesis Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Standard Oligonucleotides segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Commercial has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of RNA Oligonucleotide Synthesis Service include GenScript, OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs and Bio Basic, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for RNA Oligonucleotide Synthesis Service. Report Highlights:
(1) Global RNA Oligonucleotide Synthesis Service market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global RNA Oligonucleotide Synthesis Service market competitive situation, revenue and market share, from 2018 to 2022.
(3) China RNA Oligonucleotide Synthesis Service market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global RNA Oligonucleotide Synthesis Service segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global RNA Oligonucleotide Synthesis Service segment by type and by application and regional segment by type and by application.
(6) RNA Oligonucleotide Synthesis Service industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Standard Oligonucleotides
Micro-Oligonucleotides
Large-scale Oligonucleotides
Degenerate Primers
Long Oligos Synthesis
Market segment by application, can be divided into
Commercial
Academic Research
Market segment by players, this report covers
GenScript
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
1 Market Overview
1.1 Product Overview and Scope of RNA Oligonucleotide Synthesis Service
1.2 Global RNA Oligonucleotide Synthesis Service Market Size and Forecast
1.3 China RNA Oligonucleotide Synthesis Service Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China RNA Oligonucleotide Synthesis Service Share in Global Market, 2018-2029
1.4.2 RNA Oligonucleotide Synthesis Service Market Size: China VS Global, 2018-2029
1.5 RNA Oligonucleotide Synthesis Service Market Dynamics
1.5.1 RNA Oligonucleotide Synthesis Service Market Drivers
1.5.2 RNA Oligonucleotide Synthesis Service Market Restraints
1.5.3 RNA Oligonucleotide Synthesis Service Industry Trends
1.5.4 RNA Oligonucleotide Synthesis Service Industry Policy
2 Global Competitive Situation by Company
2.1 Global RNA Oligonucleotide Synthesis Service Revenue by Company (2018-2023)
2.2 Global RNA Oligonucleotide Synthesis Service Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global RNA Oligonucleotide Synthesis Service Concentration Ratio
2.4 Global RNA Oligonucleotide Synthesis Service Mergers & Acquisitions, Expansion Plans
2.5 Global RNA Oligonucleotide Synthesis Service Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China RNA Oligonucleotide Synthesis Service Revenue by Company (2018-2023)
3.2 China RNA Oligonucleotide Synthesis Service RNA Oligonucleotide Synthesis Service Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China RNA Oligonucleotide Synthesis Service, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 RNA Oligonucleotide Synthesis Service Industry Chain
4.2 RNA Oligonucleotide Synthesis Service Upstream Analysis
4.3 RNA Oligonucleotide Synthesis Service Midstream Analysis
4.4 RNA Oligonucleotide Synthesis Service Downstream Analysis
5 Sights by Type
5.1 RNA Oligonucleotide Synthesis Service Classification
5.1.1 Standard Oligonucleotides
5.1.2 Micro-Oligonucleotides
5.1.3 Large-scale Oligonucleotides
5.1.4 Degenerate Primers
5.1.5 Long Oligos Synthesis
5.2 By Type, Global RNA Oligonucleotide Synthesis Service Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global RNA Oligonucleotide Synthesis Service Revenue, 2018-2029
6 Sights by Application
6.1 RNA Oligonucleotide Synthesis Service Segment by Application
6.1.1 Commercial
6.1.2 Academic Research
6.2 By Application, Global RNA Oligonucleotide Synthesis Service Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global RNA Oligonucleotide Synthesis Service Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global RNA Oligonucleotide Synthesis Service Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
7.3 North America
7.3.1 North America RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America RNA Oligonucleotide Synthesis Service Market Size Market Share
7.4 Europe
7.4.1 Europe RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe RNA Oligonucleotide Synthesis Service Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific RNA Oligonucleotide Synthesis Service Market Size Market Share
7.6 South America
7.6.1 South America RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America RNA Oligonucleotide Synthesis Service Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global RNA Oligonucleotide Synthesis Service Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.3.2 By Company, U.S. RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.4.2 By Company, Europe RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.4.3 By Type, Europe RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.5.2 By Company, China RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.5.3 By Type, China RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.6.2 By Company, Japan RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.6.3 By Type, Japan RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.7.2 By Company, South Korea RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.8.2 By Company, Southeast Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.9.2 By Company, India RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.9.3 By Type, India RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia RNA Oligonucleotide Synthesis Service Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 GenScript
9.1.1 GenScript Company Information, Head Office, Market Area and Industry Position
9.1.2 GenScript Company Profile and Main Business
9.1.3 GenScript RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.1.4 GenScript RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.1.5 GenScript Recent Developments
9.2 OriGene
9.2.1 OriGene Company Information, Head Office, Market Area and Industry Position
9.2.2 OriGene Company Profile and Main Business
9.2.3 OriGene RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.2.4 OriGene RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.2.5 OriGene Recent Developments
9.3 BBI
9.3.1 BBI Company Information, Head Office, Market Area and Industry Position
9.3.2 BBI Company Profile and Main Business
9.3.3 BBI RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.3.4 BBI RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.3.5 BBI Recent Developments
9.4 Genewiz
9.4.1 Genewiz Company Information, Head Office, Market Area and Industry Position
9.4.2 Genewiz Company Profile and Main Business
9.4.3 Genewiz RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.4.4 Genewiz RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.4.5 Genewiz Recent Developments
9.5 Eurofins Genomics
9.5.1 Eurofins Genomics Company Information, Head Office, Market Area and Industry Position
9.5.2 Eurofins Genomics Company Profile and Main Business
9.5.3 Eurofins Genomics RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.5.4 Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.5.5 Eurofins Genomics Recent Developments
9.6 Gene Oracle
9.6.1 Gene Oracle Company Information, Head Office, Market Area and Industry Position
9.6.2 Gene Oracle Company Profile and Main Business
9.6.3 Gene Oracle RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.6.4 Gene Oracle RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.6.5 Gene Oracle Recent Developments
9.7 SBS Genetech
9.7.1 SBS Genetech Company Information, Head Office, Market Area and Industry Position
9.7.2 SBS Genetech Company Profile and Main Business
9.7.3 SBS Genetech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.7.4 SBS Genetech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.7.5 SBS Genetech Recent Developments
9.8 Creative Biolabs
9.8.1 Creative Biolabs Company Information, Head Office, Market Area and Industry Position
9.8.2 Creative Biolabs Company Profile and Main Business
9.8.3 Creative Biolabs RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.8.4 Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.8.5 Creative Biolabs Recent Developments
9.9 Bio Basic
9.9.1 Bio Basic Company Information, Head Office, Market Area and Industry Position
9.9.2 Bio Basic Company Profile and Main Business
9.9.3 Bio Basic RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.9.4 Bio Basic RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.9.5 Bio Basic Recent Developments
9.10 Kaneka Eurogentec SA
9.10.1 Kaneka Eurogentec SA Company Information, Head Office, Market Area and Industry Position
9.10.2 Kaneka Eurogentec SA Company Profile and Main Business
9.10.3 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.10.4 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.10.5 Kaneka Eurogentec SA Recent Developments
9.11 AltaBioscience
9.11.1 AltaBioscience Company Information, Head Office, Market Area and Industry Position
9.11.2 AltaBioscience Company Profile and Main Business
9.11.3 AltaBioscience RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.11.4 AltaBioscience RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.11.5 AltaBioscience Recent Developments
9.12 Synbio Technologies
9.12.1 Synbio Technologies Company Information, Head Office, Market Area and Industry Position
9.12.2 Synbio Technologies Company Profile and Main Business
9.12.3 Synbio Technologies RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.12.4 Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.12.5 Synbio Technologies Recent Developments
9.13 TriLink
9.13.1 TriLink Company Information, Head Office, Market Area and Industry Position
9.13.2 TriLink Company Profile and Main Business
9.13.3 TriLink RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.13.4 TriLink RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.13.5 TriLink Recent Developments
9.14 Azenta Life Science
9.14.1 Azenta Life Science Company Information, Head Office, Market Area and Industry Position
9.14.2 Azenta Life Science Company Profile and Main Business
9.14.3 Azenta Life Science RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.14.4 Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.14.5 Azenta Life Science Recent Developments
9.15 KareBay Biochem
9.15.1 KareBay Biochem Company Information, Head Office, Market Area and Industry Position
9.15.2 KareBay Biochem Company Profile and Main Business
9.15.3 KareBay Biochem RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.15.4 KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.15.5 KareBay Biochem Recent Developments
9.16 Creative Biogene
9.16.1 Creative Biogene Company Information, Head Office, Market Area and Industry Position
9.16.2 Creative Biogene Company Profile and Main Business
9.16.3 Creative Biogene RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.16.4 Creative Biogene RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.16.5 Creative Biogene Recent Developments
9.17 Generi Biotech
9.17.1 Generi Biotech Company Information, Head Office, Market Area and Industry Position
9.17.2 Generi Biotech Company Profile and Main Business
9.17.3 Generi Biotech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.17.4 Generi Biotech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.17.5 Generi Biotech Recent Developments
9.18 Primetech
9.18.1 Primetech Company Information, Head Office, Market Area and Industry Position
9.18.2 Primetech Company Profile and Main Business
9.18.3 Primetech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.18.4 Primetech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.18.5 Primetech Recent Developments
9.19 General Biosystems
9.19.1 General Biosystems Company Information, Head Office, Market Area and Industry Position
9.19.2 General Biosystems Company Profile and Main Business
9.19.3 General Biosystems RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.19.4 General Biosystems RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
9.19.5 General Biosystems Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. RNA Oligonucleotide Synthesis Service Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. RNA Oligonucleotide Synthesis Service Market Restraints
Table 3. RNA Oligonucleotide Synthesis Service Market Trends
Table 4. RNA Oligonucleotide Synthesis Service Industry Policy
Table 5. Global RNA Oligonucleotide Synthesis Service Revenue by Company (2018-2023) & (US$ million)
Table 6. Global RNA Oligonucleotide Synthesis Service Revenue Market Share by Company (2018-2023)
Table 7. Global RNA Oligonucleotide Synthesis Service Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global RNA Oligonucleotide Synthesis Service Mergers & Acquisitions, Expansion Plans
Table 9. Global RNA Oligonucleotide Synthesis Service Manufacturers Product Type
Table 10. China RNA Oligonucleotide Synthesis Service Revenue by Company (2018-2023) & (US$ million)
Table 11. China RNA Oligonucleotide Synthesis Service Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of RNA Oligonucleotide Synthesis Service Upstream (Raw Materials)
Table 13. Global RNA Oligonucleotide Synthesis Service Typical Customers
Table 14. RNA Oligonucleotide Synthesis Service Typical Distributors
Table 15. By Type, Global RNA Oligonucleotide Synthesis Service Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global RNA Oligonucleotide Synthesis Service Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global RNA Oligonucleotide Synthesis Service Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, US$ Million
Table 19. By Country, Global RNA Oligonucleotide Synthesis Service Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, US$ Million
Table 21. By Country, Global RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2029
Table 22. GenScript Company Information, Head Office, Market Area and Industry Position
Table 23. GenScript Company Profile and Main Business
Table 24. GenScript RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 25. GenScript RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 26. GenScript Recent Developments
Table 27. OriGene Company Information, Head Office, Market Area and Industry Position
Table 28. OriGene Company Profile and Main Business
Table 29. OriGene RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 30. OriGene RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 31. OriGene Recent Developments
Table 32. BBI Company Information, Head Office, Market Area and Industry Position
Table 33. BBI Company Profile and Main Business
Table 34. BBI RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 35. BBI RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 36. BBI Recent Developments
Table 37. Genewiz Company Information, Head Office, Market Area and Industry Position
Table 38. Genewiz Company Profile and Main Business
Table 39. Genewiz RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 40. Genewiz RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 41. Genewiz Recent Developments
Table 42. Eurofins Genomics Company Information, Head Office, Market Area and Industry Position
Table 43. Eurofins Genomics Company Profile and Main Business
Table 44. Eurofins Genomics RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 45. Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 46. Eurofins Genomics Recent Developments
Table 47. Gene Oracle Company Information, Head Office, Market Area and Industry Position
Table 48. Gene Oracle Company Profile and Main Business
Table 49. Gene Oracle RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 50. Gene Oracle RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 51. Gene Oracle Recent Developments
Table 52. SBS Genetech Company Information, Head Office, Market Area and Industry Position
Table 53. SBS Genetech Company Profile and Main Business
Table 54. SBS Genetech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 55. SBS Genetech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 56. SBS Genetech Recent Developments
Table 57. Creative Biolabs Company Information, Head Office, Market Area and Industry Position
Table 58. Creative Biolabs Company Profile and Main Business
Table 59. Creative Biolabs RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 60. Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 61. Creative Biolabs Recent Developments
Table 62. Bio Basic Company Information, Head Office, Market Area and Industry Position
Table 63. Bio Basic Company Profile and Main Business
Table 64. Bio Basic RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 65. Bio Basic RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 66. Bio Basic Recent Developments
Table 67. Kaneka Eurogentec SA Company Information, Head Office, Market Area and Industry Position
Table 68. Kaneka Eurogentec SA Company Profile and Main Business
Table 69. Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 70. Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 71. Kaneka Eurogentec SA Recent Developments
Table 72. AltaBioscience Company Information, Head Office, Market Area and Industry Position
Table 73. AltaBioscience Company Profile and Main Business
Table 74. AltaBioscience RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 75. AltaBioscience RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 76. AltaBioscience Recent Developments
Table 77. Synbio Technologies Company Information, Head Office, Market Area and Industry Position
Table 78. Synbio Technologies Company Profile and Main Business
Table 79. Synbio Technologies RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 80. Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 81. Synbio Technologies Recent Developments
Table 82. TriLink Company Information, Head Office, Market Area and Industry Position
Table 83. TriLink Company Profile and Main Business
Table 84. TriLink RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 85. TriLink RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 86. TriLink Recent Developments
Table 87. Azenta Life Science Company Information, Head Office, Market Area and Industry Position
Table 88. Azenta Life Science Company Profile and Main Business
Table 89. Azenta Life Science RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 90. Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 91. Azenta Life Science Recent Developments
Table 92. KareBay Biochem Company Information, Head Office, Market Area and Industry Position
Table 93. KareBay Biochem Company Profile and Main Business
Table 94. KareBay Biochem RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 95. KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 96. KareBay Biochem Recent Developments
Table 97. Creative Biogene Company Information, Head Office, Market Area and Industry Position
Table 98. Creative Biogene Company Profile and Main Business
Table 99. Creative Biogene RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 100. Creative Biogene RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 101. Creative Biogene Recent Developments
Table 102. Generi Biotech Company Information, Head Office, Market Area and Industry Position
Table 103. Generi Biotech Company Profile and Main Business
Table 104. Generi Biotech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 105. Generi Biotech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 106. Generi Biotech Recent Developments
Table 107. Primetech Company Information, Head Office, Market Area and Industry Position
Table 108. Primetech Company Profile and Main Business
Table 109. Primetech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 110. Primetech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 111. Primetech Recent Developments
Table 112. General Biosystems Company Information, Head Office, Market Area and Industry Position
Table 113. General Biosystems Company Profile and Main Business
Table 114. General Biosystems RNA Oligonucleotide Synthesis Service Models, Specifications and Application
Table 115. General Biosystems RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2018-2023
Table 116. General Biosystems Recent Developments
List of Figure
Figure 1. RNA Oligonucleotide Synthesis Service Picture
Figure 2. Global RNA Oligonucleotide Synthesis Service Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China RNA Oligonucleotide Synthesis Service Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China RNA Oligonucleotide Synthesis Service Market Share of Global
Figure 5. Global RNA Oligonucleotide Synthesis Service Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global RNA Oligonucleotide Synthesis Service Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China RNA Oligonucleotide Synthesis Service Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China RNA Oligonucleotide Synthesis Service Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. RNA Oligonucleotide Synthesis Service Industry Chain
Figure 10. Standard Oligonucleotides
Figure 11. Micro-Oligonucleotides
Figure 12. Large-scale Oligonucleotides
Figure 13. Degenerate Primers
Figure 14. Long Oligos Synthesis
Figure 15. By Type, Global RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, US$ Million
Figure 16. By Type, Global RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2029
Figure 17. Commercial
Figure 18. Academic Research
Figure 19. By Application, Global RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, US$ Million
Figure 20. By Application, Global RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2029
Figure 21. By Region, Global RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2029
Figure 22. North America RNA Oligonucleotide Synthesis Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
Figure 24. Europe RNA Oligonucleotide Synthesis Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
Figure 26. Asia Pacific RNA Oligonucleotide Synthesis Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
Figure 28. South America RNA Oligonucleotide Synthesis Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America RNA Oligonucleotide Synthesis Service Revenue Market Share, 2018-2023
Figure 30. Middle East & Africa RNA Oligonucleotide Synthesis Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 32. By Company, U.S. RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 33. By Type, U.S. RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 34. By Application, U.S. RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 35. Europe RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 36. By Company, Europe RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 37. By Type, Europe RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 38. By Application, Europe RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 39. China RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 40. By Company, China RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 41. By Type, China RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 42. By Application, China RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 43. Japan RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 44. By Company, Japan RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 45. By Type, Japan RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 46. By Application, Japan RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 47. South Korea RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 48. By Company, South Korea RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 49. By Type, South Korea RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 50. By Application, South Korea RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 51. Southeast Asia RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 52. By Company, Southeast Asia RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 53. By Type, Southeast Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 54. By Application, Southeast Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 55. India RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 56. By Company, India RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 57. By Type, India RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 58. By Application, India RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 59. Middle East & Asia RNA Oligonucleotide Synthesis Service Revenue, 2018-2029, (US$ Million)
Figure 60. By Company, Middle East & Asia RNA Oligonucleotide Synthesis Service Market Share, 2018-2023
Figure 61. By Type, Middle East & Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 62. By Application, Middle East & Asia RNA Oligonucleotide Synthesis Service Revenue Market Share, 2022 VS 2029
Figure 63. Research Methodology
Figure 64. Breakdown of Primary Interviews
Figure 65. Bottom-up Approaches
Figure 66. Top-down Approaches
Reason to Buy